Yuhan Corporation
000100
Classement en actions
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Prix de l'action
$63.22
Capitalisation boursière
$4.27B
Changement (1 jour)
-3.12%
Changement (1 an)
-23.57%
Pays
KR
Échange Yuhan Corporation (000100)
Catégorie
Healthcare
Revenus pour Yuhan Corporation (000100)
Revenus en Jun 2026 TTM : $1.72B
Selon les derniers rapports financiers de Yuhan Corporation, le chiffre d'affaires actuel de l'entreprise (TTM) est de $1.72B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $1.41B une diminution par rapport à le chiffre d'affaires de l'année 2023, qui était de $1.44B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Yuhan Corporation de 2007 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $1.72B | 13.61% |
| 2025 | $1.51B | 7.62% |
| 2024 | $1.41B | -2.06% |
| 2023 | $1.44B | 2.04% |
| 2022 | $1.41B | -0.87% |
| 2021 | $1.42B | -4.85% |
| 2020 | $1.49B | 16.39% |
| 2019 | $1.28B | -6.01% |
| 2018 | $1.36B | -0.59% |
| 2017 | $1.37B | 25.25% |
| 2016 | $1.10B | 14.05% |
| 2015 | $960.45M | 3.29% |
| 2014 | $929.82M | 3.74% |
| 2013 | $896.29M | 22.88% |
| 2012 | $729.40M | 24.46% |
| 2011 | $586.04M | -0.96% |
| 2010 | $591.75M | 6.18% |
| 2009 | $557.33M | 17.68% |
| 2008 | $473.59M | -10.14% |
| 2007 | $527.01M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $23.54B | 1,268.60% |
DE
|
|
| $23.73B | 1,280.21% |
DE
|
|
| $29.24B | 1,600.31% |
JP
|
|
| $5.85B | 240.11% |
CH
|
|
| $6.34B | 268.81% |
IN
|
